Notice ID: 7ac300a4afdb415dbc23cdd83da2fb65Combined Synopsis/Solicitation
Continuous Membrane Emulsification System
Archived on July 27, 2021. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM UTC−04:00
- Posted
- July 5, 2021
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Place of performance
- Silver Spring, MD, 20993
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- 75F40121Q00044
- Notice ID
- 7ac300a4afdb415dbc23cdd83da2fb65
Description
The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), seeks to acquire a Continuous Membrane Emulsification System capable of manufacturing the emulsions and polymeric microparticles. The Vendor shall indicate if the minimum salient characteristics have been met to be considered responsive for this requirement.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75F40121Q00044- Combined Synopsis
- Combined SynopsisCurrentJul 5, 2021
Continuous Membrane Emulsification System
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75F40121Q00044
Archive Date
Jul 27, 2021
Office Address
Beltsville, MD, 20705